Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study

Journal of Hepatology

Volumn 59, Issue 6, 2013, Pages 1184-1192

  Simón Talero, Macarena ^a   García Martínez, Rita ^a   Torrens, Maria ^a   Augustin, Salvador ^a   Gómez, Susana ^a   Pereira, Gustavo ^b   Guevara, Mónica ^b,c,d   Ginés, Pere ^b,c,d   Soriano, Germán ^c,e   Román, Eva ^c,e   Sánchez Delgado, Jordi ^c,e   Ferrer, Roser ^a   Nieto, Juan C ^e   Sunyé, Pilar ^a   Fuentes, Inma ^f   Esteban, Rafael ^a,c   Córdoba, Juan ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Albumin; Cirrhosis; Hepatic encephalopathy; Human; Treatment

Indexed keywords

ALBUMIN; RIFAXIMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ACLF; ACUTE-ON-CHRONIC LIVER FAILURE; ALB; ALBUMIN; ALBUMIN GROUP; CHESS; CIRRHOSIS; CLINICAL HEPATIC ENCEPHALOPATHY STAGING SCALE; HE; HEPATIC ENCEPHALOPATHY; HEPATIC ENCEPHALOPATHY SCORING ALGORITHM; HESA; HUMAN; IL; INTERLEUKIN; MALONDIALDEHYDE; MDA; MELD; MODEL FOR END-STAGE LIVER DISEASE; SAL; SALINE GROUP; TNF-Α; TREATMENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALBUMINS; DOUBLE-BLIND METHOD; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INJECTIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84887990741     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.020     Document Type: Article

References (37)

1. P. Ferenci, A. Lockwood, K. Mullen, R. Tarter, K. Weissenborn, and A.T. Blei Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 2002 716 721
2. J. Cordoba New assessment of hepatic encephalopathy J Hepatol 54 2011 1030 1040
3. D. Haussinguer, and F. Schliess Pathogenetic mechanisms of hepatic encephalopathy Gut 57 2008 1156 1165
4. P. Iversen, M. Sorensen, L.K. Bak, H.S. Waagepetersen, M.S. Vafaee, and P. Borghammer Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy Gastroenterology 136 2009 863 871
5. J.S. Bajaj, J. Cordoba, K.D. Mullen, P. Amodio, D.L. Shawcross, and R.F. Butterworth Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Aliment Pharmacol Ther 33 2011 739 747
6. A.T. Blei, and J. Cordoba Hepatic encephalopathy Am J Gastroenterol 96 2001 1968 1976
7. B. Als-Nielsen, L.L. Gluud, and C. Gluud Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials BMJ 328 2004 1046
8. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, and C.B. Leevy Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081
9. G. Wright, and R. Jalan Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology 46 2007 291 294
10. R. Jalan, and D. Kapoor Reserval of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid Clin Sci 106 2004 467 474
11. T.I. Hassanein, F. Tofteng, R.S. Brown Jr., B. McGuire, P. Lynch, and R. Mehta Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 46 2007 1853 1862
12. R. Bañares, F. Nervens, F.S. Larsen, R. Jalan, A. Albillos, and M. Dollinger Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial Hepatology 57 2013 1153 1162
13. R. Jalan, K. Schnurr, R.P. Mookerjee, S. Sen, L. Cheshire, and S. Hodges Alterations in the functional capacity of albumin in patient with decompensated cirrhosis is associated with increased mortality Hepatology 50 2009 555 564
14. R.J. Groszmann Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences Hepatology 20 1994 1359 1363
15. P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, and L. Ruiz-del-Arbol Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
16. M. Martín-Llahí, M.N. Pépin, M. Guevara, F. Díaz, A. Torre, and A. Monescillo Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study Gastroenterology 134 2008 1352 1359
17. R. Jalan, and R. Williams Acute-on-chronic liver failure: pathophysiological basis of therapeutic options Blood Purif 20 2002 252 261
18. T.I. Hassanein, R.C. Hilsabeck, and W. Perry Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA) Dig Dis Sci 53 2008 529 538
19. M. Ortiz, J. Córdoba, and E. Doval Development of a clinical hepatic encephalopathy staging scale Aliment Pharmacol Ther 26 2007 859 867
20. J.R. Huizenga, C.H. Gips, H.O. Conn, and P.L. Jansen Determination of ammonia in ear-lobe capillary blood is an alternative to arterial blood ammonia Clin Chim Acta 239 1995 65 70
21. J.R. Huizenga, A. Tangerman, and C.H. Gips A rapid method for blood ammonia determination using the new blood ammonia checker (BAC) II Clin Chim Acta 210 1992 153 155
22. J. Cordoba, J. Lopez-Hellin, and M. Planas Normal protein diet for episodic hepatic encephalopathy: results of a randomized study J Hepatol 41 2004 38 43
23. P.S. Kamath The need for better clinical trials Hepatology 48 2008 1 3
24. C. Buechler, M. Ritter, E. Orsó, T. Langmann, J. Klucken, and G. Schmitz Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli J Leukoc Biol 67 2000 97 103
25. A. Ginès, G. Fernández-Esparrach, A. Monescillo, C. Vila, E. Domènech, and R. Abecasis Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis Gastroenterology 111 1996 1002 1010
26. R. García-Martínez, P. Caraceni, M. Bernardi, P. Gines, V. Arroyo, and R. Jalan Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications Hepatology 2013 10.1002/hep.26338 [Epub ahead of print]
27. M.D. Hill, R.H. Martin, Y.Y. Palesch, D. Tamariz, B.D. Waldman, and K.J. Ryckborst The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis Stroke 42 2011 1621 1625
28. M. Boada, P. Ortiz, F. Anaya, I. Hernández, J. Muñoz, and L. Núñez Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization Drug News Perspect 22 2009 325 339
29. O. Waidmann, F. Brunner, E. Herrmann, S. Zeuzem, A. Piiper, and B. Kronenberger Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis J Hepatol 58 2013 956 961
30. J. Bustamante, A. Rimola, P.J. Ventura, M. Navasa, I. Cirera, and V. Reggiardo Prognostic significance of hepatic encephalopathy in patients with cirrhosis J Hepatol 30 1999 890 895
31. I. Les, E. Doval, R. García-Martínez, M. Planas, G. Cárdenas, and P. Gómez Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study Am J Gastroenterol 106 2011 Jun 1081 1088
32. R. Moreau, R. Jalan, and P. Gines Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 2013 10.1053/j.gastro.2013.02.042 pii: S0016-5085(13)00291-6 [Epub ahead of print]
33. J.G. Abraldes, A. Albillos, R. Bañares, J. Turnes, R. González, and J.C. García-Pagán Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial Gastroenterology 136 2009 1651 1658
34. A. Rovira, B. Mínguez, F.X. Aymerich, C. Jacas, E. Huerga, and J. Córdoba Decreased white matter lesion volume and improved cognitive function after liver transplantation Hepatology 46 2007 1485 1490
35. V. La Mura, J.C. Reverter, A. Flores-Arroyo, S. Raffa, E. Reverter, and S. Seijo Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension Gut 60 2011 1133 1138
36. R.G. Romanelli, G. La Villa, G. Barletta, F. Vizzutti, F. Laninin, and U. Arena Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial World J Gastroenterol 12 2006 1403 1407
37. M. Guevara, C. Terra, A. Nazar, E. Solà, J. Fernández, and M. Pavesi Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study J Hepatol 57 2012 759 765